Search research articles
Contact Us
Filters
Showing results (1131-1140 of 1,231) with videos related to
Page
of 124
Sort By:
Physical Review Letters
|
October 10, 2006
K isomers in 254No: probing single-particle energies and pairing strengths in the heaviest nuclei
S K Tandel, T L Khoo, D Seweryniak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2019
Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)
Christine B Ambrosone, Gary R Zirpoli, Alan D Hutson, et al.
Leukemia & Lymphoma
|
February 28, 2015
Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997
David M Lucas, Amy S Ruppert, Gerard Lozanski, et al.
Journal of the National Cancer Institute
|
April 3, 2020
Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival
Rikki A Cannioto, Alan Hutson, Shruti Dighe, et al.
The Pharmacogenomics Journal
|
September 4, 2013
Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer
S Yao, L E Sucheston, H Zhao, et al.
Breast Cancer Research and Treatment
|
July 19, 2011
Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)
Lara E Sucheston, Hua Zhao, Song Yao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2014
SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer
George T Budd, William E Barlow, Halle C F Moore, et al.
Veterinary Immunology and Immunopathology
|
June 25, 1998
Report of the Second Equine Leucocyte Antigen Workshop, Squaw valley, California, July 1995
D P Lunn, M A Holmes, D F Antczak, et al.
Physical Review Letters
|
October 13, 2007
New determination of the astrophysical S factor SE1 of the 12C(alpha,gamma)16O reaction
X D Tang, K E Rehm, I Ahmad, et al.
Physical Review Letters
|
February 21, 2006
Breakdown of K selection in 178Hf
A B Hayes, D Cline, C Y Wu, et al.
Page
of 124
Search research articles
Search
Showing results (1131-1140 of 1,231) with videos related to
Sort By:
Page
of 124
Physical Review Letters
|
October 10, 2006
K isomers in 254No: probing single-particle energies and pairing strengths in the heaviest nuclei
S K Tandel, T L Khoo, D Seweryniak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2019
Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)
Christine B Ambrosone, Gary R Zirpoli, Alan D Hutson, et al.
Leukemia & Lymphoma
|
February 28, 2015
Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997
David M Lucas, Amy S Ruppert, Gerard Lozanski, et al.
Journal of the National Cancer Institute
|
April 3, 2020
Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival
Rikki A Cannioto, Alan Hutson, Shruti Dighe, et al.
The Pharmacogenomics Journal
|
September 4, 2013
Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer
S Yao, L E Sucheston, H Zhao, et al.
Breast Cancer Research and Treatment
|
July 19, 2011
Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)
Lara E Sucheston, Hua Zhao, Song Yao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2014
SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer
George T Budd, William E Barlow, Halle C F Moore, et al.
Veterinary Immunology and Immunopathology
|
June 25, 1998
Report of the Second Equine Leucocyte Antigen Workshop, Squaw valley, California, July 1995
D P Lunn, M A Holmes, D F Antczak, et al.
Physical Review Letters
|
October 13, 2007
New determination of the astrophysical S factor SE1 of the 12C(alpha,gamma)16O reaction
X D Tang, K E Rehm, I Ahmad, et al.
Physical Review Letters
|
February 21, 2006
Breakdown of K selection in 178Hf
A B Hayes, D Cline, C Y Wu, et al.
Page
of 124